Palo Alto Networks remains a sell as soft guidance, risk factors, and a premium valuation outweigh recent operational strength. Q1 FY 2026 delivered steady 16% YoY revenue growth and robust profitability, but next-gen ARR growth decelerated from 32% to 29%. Guidance for Q2 and FY 2026 signals deceleration in revenue, RPO, and next-gen ARR growth. This hints at potentially weakening demand.
A ~30% pullback resets entry into a high-conviction AI infrastructure story, with demand, pipeline strength, and hyperscaler commitments still firmly intact. Revenue volatility reflects supply timing, not demand weakness, as sold-out capacity and strong ARR shift recognition forward rather than destroy value. Execution risk remains but is increasingly de-risked by booked ARR, hyperscaler contracts, and improving visibility into capacity coming online.
Netskope receives a buy rating, driven by its proprietary NewEdge infrastructure and accelerating ARR growth. NTSK's edge-based SASE platform delivers superior security and near-zero latency, supporting robust AI and digitalization trends. ARR growth re-accelerated to 34% y/y in Q3 2026, with strong net retention and significant upsell potential.
Progress Software remains a "Buy," leveraging disciplined M&A and strong integration to drive alpha amid market uncertainty. PRGS demonstrates organic ARR growth and robust 39% pro forma operating margins, qualifying as a "Rule of 40" company. The portfolio's diversification across DevOps, databases, and collaboration tools enables cross-selling and business stability.
ARMOUR Residential REIT gets its hold rating reaffirmed, agreeing with the latest Wall Street hold consensus. Although recent revenue growth impressed, there is still the topic of funding costs for a mortgage REIT, its competitive position among peers, and margins. Despite a nearly +16% fwd dividend yield and monthly payouts, readers should also consider growth history and payout ratios.
Nebius Group N.V. has explosive revenue and ARR growth fueled by AI infrastructure investments. The NBIS ARR is projected to reach $7–$9B by the end of next year but comes at the expense of shareholder equity, a headwind you will face. Heavy losses and ongoing cash burn are expected for NBIS through 2026.
I like a lot of REITs, but not all of them. Quite a few of them are overleveraged, poorly managed, and own troubled assets. I present three popular REITs to avoid.
Cellebrite remains a "Buy" as federal demand rebounds and platform adoption accelerates, supporting a strong long-term growth outlook. The federal segment returned to year-over-year growth in Q3, removing the primary bear case and confirming demand was delayed, not lost. Inseyets migration and rapid cloud/SaaS ARR growth—Guardian cloud ARR up >100% for five quarters—position CLBT for outsized ARR acceleration into 2026.
Nebius Group (NYSE:NBIS) is nearing EBITDA profitability, driven by rapid ARR growth and AI hyperscaler contracts. NBIS targets 2025 ARR of $900M–$1.1B and 2026 ARR of $7B–$9B, reflecting hyperscaler deal momentum. Valuation models indicate 61%–159% upside, but significant CapEx, dilution, and leverage risks require close monitoring.
Listen up, dividend overachievers! With a mere $2,500 per stock or exchange traded fund (ETF), it's entirely possible to bring in $3,500 worth of passive income per year.
PANW's SASE ARR jumps 34% year over year, surpassing $1.3B, fueled by major wins and rising secure browser demand.
Nebius delivered 355% Y/Y revenue growth in Q3, driven by surging AI infrastructure demand. The AI computing platform is set for a massive ARR uplift, with guidance of $7-9B next year, outpacing rivals like CoreWeave in the GPU-as-a-Service market. New hyperscaler GPU deals, growing adoption of new inference platforms, and next year's Vera Rubin GPU platform from Nvidia pose catalysts for growth.